A simple formula for individualising ceftazidime dosage administered by continuous infusion in patients with haematological malignancies

International Journal of Antimicrobial Agents

Volumn 27, Issue 6, 2006, Pages 553-556

  Dailly, Eric ^a   Brun, Anne ^a   Kergueris, Marie France ^a   Victorri Vignoli, Caroline ^a   Milpied, Noël ^a   Jolliet, Pascale ^a  

^a HÔTEL DIEU   (France)

Author keywords

Ceftazidime; Continuous infusion; Pharmacokinetics

Indexed keywords

CEFTAZIDIME; CREATININE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; DOSE KIDNEY FUNCTION RELATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG MONITORING; FEMALE; HEMATOLOGIC DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MYELOMA; NEUTROPENIA; PRIORITY JOURNAL; STEADY STATE;

ADULT; ANTI-BACTERIAL AGENTS; CEFTAZIDIME; FEMALE; FEVER; HEMATOLOGIC NEOPLASMS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; NEUTROPENIA; RETROSPECTIVE STUDIES;

EID: 33646875932     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2005.12.014     Document Type: Article

References (13)

1. Rains C.P., Bryson H.M., Peters D.H., and Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 49 (1995) 577-617
2. Mouton J.W., and Vinks A.A. Is continuous infusion of beta-lactam antibiotics worthwhile? Efficacy and pharmacokinetic considerations. J Antimicrob Chemother 38 (1996) 5-15
3. Benko A.S., Cappelletty D.M., Kruse J.A., and Rybak M.J. Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections. Antimicrob Agents Chemother 40 (1996) 691-695
4. Nicolau D.P., Nightingale C.H., Banevicius M.A., Fu Q., and Quintiliani R. Serum bactericidal activity of ceftazidime: continuous infusion versus intermittent injections. Antimicrob Agents Chemother 40 (1996) 61-64
5. Mouton J.W., and den Hollander J.G. Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model. Antimicrob Agents Chemother 38 (1994) 931-936
6. Daenen S., Erjavec Z., Uges D.R., De Vries-Hospers H.G., De Jonge P., and Halie M.R. Continuous infusion of ceftazidime in febrile neutropenic patients with acute myeloid leukemia. Eur J Clin Microbiol Infect Dis 14 (1995) 188-192
7. Pea F., Viale P., Damiani D., et al. Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure. Antimicrob Agents Chemother 49 (2005) 3550-3553
8. Angus B.J., Smith M.D., Suputtamongkol Y., et al. Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis. Br J Clin Pharmacol 50 (2000) 184-191
9. Nyhlen A., Ljungberg B., and Nilsson-Ehle I. Pharmacokinetics of ceftazidime in febrile neutropenic patients. Scand J Infect Dis 33 (2001) 222-226
10. Rowland M., and Tozer T.N. Constant-rate regimens. In: Rowland M., and Tozer T.N. (Eds). Clinical pharmacokinetics-concepts and applications. 2nd ed. (1989), Lea & Febiger, Malvern
11. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
12. Frame B.C., Facca B.F., Nicolau D.P., and Triesenberg S.N. Population pharmacokinetics of continuous infusion ceftazidime. Clin Pharmacokinet 37 (1999) 343-350
13. Wasen E., Isoaho R., Mattila K., Vahlberg T., Kivela S.L., and Irjala K. Estimation of glomerular filtration rate in the elderly: a comparison of creatinine-based formulae with serum cystatin C. J Intern Med 256 (2004) 70-78